sur Jaguar Health, Inc. (NASDAQ:JAGX)
Jaguar Health to Present at Emerging Growth Conference
Jaguar Health, Inc. (NASDAQ:JAGX) has announced that CEO Lisa Conte will present at the Emerging Growth Conference on February 18, 2025. The virtual event requires online registration for participation, and a replay will be available on EmergingGrowth.com and YouTube.
Jaguar Health focuses on developing proprietary prescription medicines derived from rainforest plants, addressing gastrointestinal issues like chronic diarrhea. Their subsidiary, Napo Pharmaceuticals, developed Mytesi®, an FDA-approved treatment for noninfectious diarrhea in HIV/AIDS patients. Napo Therapeutics, formed in Italy, aims to expand crofelemer's access in Europe.
The announcement includes forward-looking statements about the presentation. Jaguar Health cautions that these statements are predictions, subject to risks and uncertainties. The company does not intend to update statements unless legally required.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Jaguar Health, Inc.